NCT01713608View on ClinicalTrials.gov

A Dose-escalation Study to Investigate Safety and Toleration of OZ439

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Malaria
Interventions
DRUG

OZ439

OZ439 x mg once daily for 3 days with milk

Trial Locations (1)

CR77YE

Richmond Pharmacology Ltd, Croydon

All Listed Sponsors
lead

Medicines for Malaria Venture

OTHER

NCT01713608 - A Dose-escalation Study to Investigate Safety and Toleration of OZ439 | Biotech Hunter | Biotech Hunter